Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21952195 | 0.83 | — | — | |
| SCHEMBL2725643 | 0.82 | STK17B (0.38) | STK17BSTK17A | |
| SCHEMBL29437385 | 0.80 | STK17B (0.55) | STK17BSTK17A | |
| SCHEMBL2722836 | 0.80 | STK17B (0.55) | STK17BSTK17A | |
| SCHEMBL4187304 | 0.78 | STK17A (0.35) | STK17BSTK17A | |
| SCHEMBL17836544 | 0.76 | PTK2 (0.31) | — | |
| SCHEMBL23868053 | 0.76 | STK17B (0.52) | STK17BSTK17A | |
| SCHEMBL2724784 | 0.76 | STK17B (0.34) | STK17BSTK17A | |
| SCHEMBL21967063 | 0.75 | SYK (0.30) | — | |
| SCHEMBL21967074 | 0.74 | STK17B (0.33) | STK17BSTK17A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3653209-A1 | TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY | G1 Therapeutics, Inc. (US) | 2020-05-20 | — | — | EP | disclosed |